Durvalumab Therapy Following Chemoradiation vs Chemoradiation Alone in Patients With Stage III NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Durvalumab Therapy Following Chemoradiation Compared With a Historical Cohort Treated With Chemoradiation Alone in Patients With Stage III Non-Small Cell Lung Cancer: A Real-World Multicentre Study
Eur. J. Cancer 2021 Jan 01;142(xx)83-91, A Desilets, F Blanc-Durand, S Lau, T Hakozaki, R Kitadai, J Malo, W Belkaid, C Richard, M Messaoudene, L Cvetkovic, S Kazandjian, M Tehfe, M Florescu, K Jao, N Daaboul, S Owen, B Shieh, J Agulnik, V Cohen, C Charbonneau, N Marcoux, N Blais, NB Leighl, PA Bradbury, G Liu, FA Shepherd, H Bahig, B Routy, A Sacher, A ElkriefFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.